These final results, along with a preceding report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the principle of focusing on ACKR3 as a unique solution to modulate the opioid system, which could open new therapeutic avenues for opioid-related Diseases. Research on conolidine is https://josephl749bvj1.blogproducer.com/profile